Calliditas Therapeutics Ab (CALT) - News Archive

Showing 2 of 2 results.

Extended Orphan Drug Exclusivity for TARPEYO: A Major Breakthrough in Rare Disease Treatment

Calliditas Therapeutics AB, a renowned pharmaceutical company, recently made a groundbreaking announcement that has sent ripples of excitement throughout the medical community. The US Food and Drug Administration (FDA)...

Mar 6, 2024 • Major Pharmaceutical Preparations Industry Products & Services NASDAQ

Calliditas Therapeutics Secures Euro 92 Million Loan from Athyrium Capital, Achieves High Revenue Per Employee amidst Challenges.

In a significant move to strengthen its financial position, Calliditas Therapeutics AB (Nasdaq: CALT) and (Nasdaq Stockholm: CALTX) have recently announced the successful refinancing of its existing term loan. The compa...

Dec 27, 2023 Personnel Announcements NASDAQ